Literature DB >> 12324391

Application of new biological approaches to stimulate sensory repair and protection.

Matthew C Holley1.   

Abstract

The inner ear governs hearing and balance via six sense organs, each composed of a few thousand mechanosensory hair cells. Most inner ear disorders involve irreversible loss of hair cells and their associated nerves. They are a function of age, genetic abnormalities and environmental factors such as noise and the use of ototoxic drugs. The genetics and cell biology of the inner ear have revealed some key molecular mechanisms of development and sensory degeneration that raise hopes for new therapeutic approaches to the regeneration of sensory function. This review highlights these advances and the approaches that might be taken to effect protection and repair. It concludes with the suggestion that we can expect tangible, practical progress towards the clinic over the next 5-10 years and that, to provide the training and skills required to take full advantage of emerging technologies, we should forge much closer links between specialist clinicians and basic scientists.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12324391     DOI: 10.1093/bmb/63.1.157

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  13 in total

1.  Neural stem cells injected into the sound-damaged cochlea migrate throughout the cochlea and express markers of hair cells, supporting cells, and spiral ganglion cells.

Authors:  Mark A Parker; Deborah A Corliss; Brianna Gray; Julia K Anderson; Richard P Bobbin; Evan Y Snyder; Douglas A Cotanche
Journal:  Hear Res       Date:  2007-06-20       Impact factor: 3.208

2.  Development of a microfluidics-based intracochlear drug delivery device.

Authors:  William F Sewell; Jeffrey T Borenstein; Zhiqiang Chen; Jason Fiering; Ophir Handzel; Maria Holmboe; Ernest S Kim; Sharon G Kujawa; Michael J McKenna; Mark M Mescher; Brian Murphy; Erin E Leary Swan; Marcello Peppi; Sarah Tao
Journal:  Audiol Neurootol       Date:  2009-11-16       Impact factor: 1.854

3.  Inner ear drug delivery via a reciprocating perfusion system in the guinea pig.

Authors:  Zhiqiang Chen; Sharon G Kujawa; Michael J McKenna; Jason O Fiering; Mark J Mescher; Jeffrey T Borenstein; Erin E Leary Swan; William F Sewell
Journal:  J Control Release       Date:  2005-11-07       Impact factor: 9.776

Review 4.  Biotechnology in the treatment of sensorineural hearing loss: foundations and future of hair cell regeneration.

Authors:  Mark A Parker
Journal:  J Speech Lang Hear Res       Date:  2011-03-08       Impact factor: 2.297

5.  Fate of mammalian cochlear hair cells and stereocilia after loss of the stereocilia.

Authors:  Shuping Jia; Shiming Yang; Weiwei Guo; David Z Z He
Journal:  J Neurosci       Date:  2009-12-02       Impact factor: 6.167

6.  Inner ear hair cells produced in vitro by a mesenchymal-to-epithelial transition.

Authors:  Zhengqing Hu; Jeffrey T Corwin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-25       Impact factor: 11.205

7.  Local drug delivery with a self-contained, programmable, microfluidic system.

Authors:  J Fiering; M J Mescher; E E Leary Swan; M E Holmboe; B A Murphy; Z Chen; M Peppi; W F Sewell; M J McKenna; S G Kujawa; J T Borenstein
Journal:  Biomed Microdevices       Date:  2009-06       Impact factor: 2.838

8.  Localized cell and drug delivery for auditory prostheses.

Authors:  Jeffrey L Hendricks; Jennifer A Chikar; Mark A Crumling; Yehoash Raphael; David C Martin
Journal:  Hear Res       Date:  2008-06-07       Impact factor: 3.208

9.  Functional evaluation of a cell replacement therapy in the inner ear.

Authors:  Zhengqing Hu; Mats Ulfendahl; Diane M Prieskorn; Petri Olivius; Josef M Miller
Journal:  Otol Neurotol       Date:  2009-06       Impact factor: 2.311

Review 10.  Inner ear drug delivery for auditory applications.

Authors:  Erin E Leary Swan; Mark J Mescher; William F Sewell; Sarah L Tao; Jeffrey T Borenstein
Journal:  Adv Drug Deliv Rev       Date:  2008-09-21       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.